NAB-PACLITAXEL
Clinical trials for NAB-PACLITAXEL explained in plain language.
Never miss a new study
Get alerted when new NAB-PACLITAXEL trials appear
Sign up with your email to follow new studies for NAB-PACLITAXEL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for aggressive breast cancer: chemo combo trial underway
Disease control Recruiting nowThis study tests two different chemotherapy drug combinations in people with advanced triple-negative breast cancer, a fast-growing type. About 414 participants will receive either nab-paclitaxel plus carboplatin or nab-paclitaxel plus capecitabine. The goal is to see which combi…
Matched conditions: NAB-PACLITAXEL
Phase: PHASE2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated May 26, 2026 03:08 UTC
-
New combo may treat kidney cancer without removing the organ
Disease control Recruiting nowThis study tests whether a combination of two drugs (tislelizumab and nab-paclitaxel) can treat renal pelvic cancer while avoiding removal of the kidney. About 35 adults with early-stage cancer that hasn't spread will receive the drugs, and if the tumor shrinks enough, they may g…
Matched conditions: NAB-PACLITAXEL
Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated May 26, 2026 03:05 UTC
-
New hope for Triple-Negative breast cancer: which drug combo works best before surgery?
Disease control Recruiting nowThis study tests two different chemotherapy combinations (nab-paclitaxel plus carboplatin vs. nab-paclitaxel plus epirubicin) given before surgery to shrink tumors in people with triple-negative breast cancer. The goal is to see which combo works better at eliminating cancer cell…
Matched conditions: NAB-PACLITAXEL
Phase: PHASE2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated May 26, 2026 03:00 UTC